Navigation Links
Cancer Drug Avastin Makes Inroads Against Ovarian Tumors
Date:6/5/2011

By Amanda Gardner
HealthDay Reporter

SATURDAY, June 4 (HealthDay News) -- Two new studies indicate that a common cancer drug, Avastin, may benefit both early stage ovarian cancer patients and women whose cancer has recurred.

In both studies, presented Saturday at the annual meeting of the American Society of Clinical Oncology in Chicago, Avastin (bevacizumab) was added to standard chemotherapy.

But the high cost of Avastin (as much as $6,000 a month) could be prohibitive, especially given that other therapeutic options are available to women in each group, said Dr. Kristine Zanotti, a gynecologic oncologist with University Hospitals of Cleveland.

"This is interesting but not practice-changing," she said. Zanotti was not involved with the research.

According to the American Cancer Society, ovarian cancer is the fifth most common cancer among women, but it is especially deadly because it is often caught too late for effective treatment. Nearly 14,000 American women died of ovarian cancer in 2010, the cancer society said.

The first of the two studies tracked 484 women whose ovarian malignancies had recurred but who had a relatively good prognosis based on their response to earlier chemotherapy.

Participants were randomly chosen to receive standard chemotherapy alone or chemotherapy plus Avastin. The Avastin (or placebo in the placebo arm) treatment was continued after the end of chemotherapy until the disease returned, at which point it was stopped.

After two years, investigators saw a 52 percent reduction in the risk of a recurrence, or 12.4 months in those patients taking Avastin, compared to 8.4 months in the standard chemo-alone group.

Almost 80 percent of women receiving Avastin saw their tumors shrink, compared to 57 percent of those receiving chemotherapy alone. The tumors in the Avastin group also stayed smaller for longer, the research team noted.

The side effec
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Enhancing arrest of cell growth to treat cancer in mice
2. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
3. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
4. Low forms of cyclin E reduce breast cancer drugs effectiveness
5. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
6. Soft drinks may increase risk of pancreatic cancer
7. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
8. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
9. Single gene mutation induces endometrial cancer
10. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
11. Molecular pathways linked to sex, age affect outcomes in lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Drug Avastin Makes Inroads Against Ovarian Tumors
(Date:5/5/2015)... May 05, 2015 Buckeye Health Plan ... new CEO and plan president of Buckeye Health Plan. ... the position immediately. , Hill has more than 28 ... the Pacific Northwest, from managed care to large health ... and CEO of HealthPlus of Michigan, a health plan ...
(Date:5/5/2015)... San Francisco, California (PRWEB) May 05, 2015 ... company based in San Francisco, leads an international initiative ... in order to extend the human lifespan. Scientists ... clocks inherent to women, from the initiation of her ... reveal a possible mechanism for aging and, ultimately, extend ...
(Date:5/5/2015)... May 05, 2015 HealthSlide, ... innovative interoperability solutions for hospitals nationwide, has announced ... calculator. Hospital CIOs and CTOs can access the ... calculator shows both initial and ongoing savings of ... , “Our nation’s hospitals pay an average of ...
(Date:5/5/2015)... 05, 2015 After record-breaking sales of ... 2014, Walgreens introduces the Cookies & Cream flavor at ... Extend Nutrition has continually raised the bar for nutritional ... combined with an unprecedented nutritional profile, backed by international ... Extend Nutrition will launch additional new products and expand ...
(Date:5/5/2015)... OR (PRWEB) May 05, 2015 Every year, ... eye seasons. Turns out, the worst dry eye season is ... count spikes in most of the United States. The only ... Fresh water advocate Sharon Kleyne, host of the Sharon Kleyne ... eye on her radio show of May 11, 2015. Kleyne ...
Breaking Medicine News(10 mins):Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:HealthSlide Launches ROI Cost Calculator 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3
... ... Before, ... adolescent meningococcal,vaccinations are included in the 2008 Childhood and Adolescent Immunization,Schedules ... the American Academy of Pediatrics (AAP), and the,American Academy of Family ...
... CA Mandate Weakens After SEIU Contributes $450K to Prop ... ... must,be "mean" or people will not be compelled to buy health insurance under ... the financial projections for a similar plan pending in,California., As reported in ...
... (IDFA) President and CEO Connie Tipton today issued the,following ... draft report on animal cloning., "Clearly the European ... ago with respect to assessing the safety and unintended ... report is,simply the first step for EFSA and the ...
... Californians too high, to push the legislation through without needed ... ... As the State Senate,prepares to consider Assembly Bill X1-1, the compromise ... Nunez, the state,s insurance agents urged lawmakers to make,the fixes that will ...
... Hy-Vee officials announced,today that a new generic prescription drug ... supermarkets and drugstores., The program offers a 30-day ... $4,per prescription. The medicines on the list include antibiotics ... diabetes,cholesterol and digestive issues., There are no forms ...
... sexes evolved , FRIDAY, Jan. 11 (HealthDay News) -- One of ... gender development in humans. , Duke University researchers report on the ... , In research with Phycomyces blakesleeanus , the Duke team ... these versions sexM (sex minus) and sexP (sex plus). Both encode ...
Cached Medicine News:Health News:Health Groups Release 2008 Immunization Schedules 2Health News:MA Proponent of Health Insurance Mandate Says 'Mean' Penalties Needed to Force People to Buy Insurance 2Health News:IDFA: Dairy Processors Urge Further Review of Cloning 2Health News:Insurance Agents Call for State Senate to Improve California's Health Care Reform Compromise 2Health News:Hy-Vee Unveils New Generic Drug Program 2Health News:Fungus Sheds Light on Development of Human Genders 2
(Date:5/4/2015)... GRAFTON, Wis. , May 4, 2015 /PRNewswire/ ... of high-quality consumables used in dental restorative procedures, ... is a producer of an innovative sectional matrix ... "We are excited about the opportunity to ... accessories," said John Frymark , VP and ...
(Date:5/4/2015)... , May 4, 2015  Fox Three Partners, ... on the lower middle market, announced today the ... in 1969 and based in Newport ... range of radiation products for medical professionals as ... with Peninsula Capital Partners ("Peninsula"), an investment company ...
(Date:5/4/2015)...   The New York Times sought out ... plastic surgeon, Dr. Rod Rohrich . Kybella, recently ... to reduce fat deposits under the chin. ... active ingredient in Kybella, deoxycholic acid, dissolves the fat ... to reshape this area without surgery. "So many consumers ...
Breaking Medicine Technology:Microbrush International Announces Acquisition of DentiSmart 2Fox Three Partners, LLC Acquires Burlington Medical Supplies, Inc. 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3
... 2010 Valeant Pharmaceuticals International, Inc. (NYSE: ... Board of Directors (the "Board") has declared a one-time ... Dividend") that shareholders of record as of the close ... will be entitled to receive on December 22, 2010. ...
... Ind., Nov. 3, 2010 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... secured revolving credit facility, effective November 3, 2010.  The credit ... borrowing capacity up to $300 million. The credit facility has ...
Cached Medicine Technology:Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 2Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 3Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 4Symmetry Medical Closes $200 Million Credit Facility 2Symmetry Medical Closes $200 Million Credit Facility 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: